[Transient hyperglycemia following intra-peritoneal irrigation with 5% glucose in a patient with pseudomyxoma

Rie Mieda1, Chizu Aso, Koichi Nishikawa

  • 1Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi City 371-8511, Japan.

Masui. the Japanese Journal of Anesthesiology
|August 25, 2007
PubMed

Insights

Intra-peritoneal irrigation with glucose for pseudomyxoma peritonei can cause transient hyperglycemia. Monitoring blood glucose levels during and after this procedure is recommended to manage this complication.

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Complications

Background:

  • Pseudomyxoma peritonei involves neoplastic epithelium producing mucopolysaccharides, leading to mucinous ascites.
  • Complete surgical removal of mucinous ascites is challenging.
  • Intra-peritoneal lavage with glucose or dextrose is used to prevent mucus reaccumulation and complications like bowel obstruction.

Observation:

  • A 72-year-old woman with pseudomyxoma peritonei underwent intra-peritoneal irrigation with 5% glucose solution.
  • The patient developed transient hyperglycemia (serum glucose 266 mg x dl(-1)) shortly after the irrigation procedure.
  • Hemodynamic and oxygenation data remained stable throughout the observation period.

Findings:

  • The patient's hyperglycemia was presumed to be a direct result of the intra-peritoneal glucose instillation.
  • Serum glucose levels returned to 154 mg x dl(-1) one hour post-surgery, indicating a transient effect.
  • No other immediate complications were noted, and the patient recovered uneventfully.

Implications:

  • Awareness of potential acute hyperglycemia is crucial for clinicians performing intra-peritoneal glucose irrigation.
  • Glucose monitoring during and after irrigation is recommended to detect and manage this potentially dangerous complication.
  • This case highlights the importance of vigilant patient monitoring for metabolic disturbances following specific surgical interventions.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...